Lipoxin A4 (LXA4) is a potent eicosanoid that inhibits IL-1β-induced activation of human fibroblast-like synoviocytes (FLS) via the LXA4 receptor (ALXR). Serum amyloid A (SAA) is an acute phase reactant with cytokine-like properties. SAA has been shown to bind the same seven transmembrane G protein-coupled receptor ligated by LXA4. Here we compared the inflammatory responses of lipid (LXA4) and peptide (SAA) ligands in human FLS via the shared ALX and characterized their downstream signaling. LXA4 induced stimulation of tissue inhibitors of metalloproteinase-2, whereas SAA induced interleukin-8 and matrix metalloproteinase-3 production. SAA up-regulated NF-kB and AP-1 DNA binding activity, while LXA4 markedly inhibited these responses after IL-1β stimulation. A human IL-8 promoter luciferase construct was transfected into CHO cells stably expressing ALXR in order to determine the role of NF-kB and/or AP-1 in the regulation of IL-8 gene expression. The NF-kB pathway proved to be the preeminent for the biological responses elicited by both ligands. These findings suggest that two endogenous molecules, targeting a common receptor, could participate in the pathogenesis of inflammatory arthritis by differentially regulating inflammatory responses in tissues expressing the ALXR.
BinghamC.O.3rd. 2002. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation.J. Rheumatol.65(S):3.
2.
MigitaK., HondaS., YamasakiS., HiraiY, FukudaT., AoyagiT., KitaM., IdaH., TsukadaT., KawakamiA., KawabeY., and EguchiK.. 2000. Regulation of rheumatoid synovial cell growth by ceramide.Biochem. Biophys. Res. Commun.269: 70.
3.
KonttinenY.T., LiT-F., HukkanenM., MaJ., XuJ-W., and VirtanenI.. 2000. Fibroblast biology. Signals targeting the synovial fibroblast in arthritis.Arthritis Res.2: 348.
4.
KawanakaN., YamamuraM., AitaT., MoritaY., OkamotoA., KawashimaM., IwahashiM., UenoA., OhmotoY., and MakinoH.. 2002. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.Arthritis Rheum.46: 2578.
5.
BischofR.J., ZafiropoulosD., HamiltonJ.A., and CampbellI.K.. 2000. Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation.Clin. Exp. Immunol.119: 361.
6.
WoolleyD.E., and TetlowL.C.. 2000. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.Arthritis Res.2: 5.
7.
YamamuraY., GuptaR., MoritaY., HeX., PaiR., EndresJ., FreibergA., ChungK., and FoxD.A.. 2001. Effector function of resting T cells: activation of synovial fibroblasts.J. Immunol.166: 2270.
8.
MainiR.N., Plater-ZyberkC., and AndrewE.. 1987. Autoimmunity in rheumatoid arthritis. An approach via a study of B lymphocytes.Rheum. Dis. Clin. North Am.2: 319.
9.
FiresteinG.S.. 1996. Invasive fibroblast-like synoviocytes in rheumatoid arthritis.Rheum. Arthritis39: 1781.
10.
YamanishiY., and FiresteinG.S.. 2001. Pathogenesis of rheumatoid arthritis: the role of synoviocytes.Rheum. Dis. Clin. North Am.2: 355.
11.
GeorganasC., LiuH., PerlmanH., HoffmannA., ThimmapayaB., and PopeR.M.. 2000. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: dominant role for NF-kB but not C/EBP or c-Jun.J. Immunol.165: 7199.
12.
FeldmannM.. 2001. Pathogenesis of arthritis: recent research progress.Nat. Immunol.2: 771.
13.
MukaidaN., HaradaA., YasumotoK., and MatsushimaK.. 1992. Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factor (MCAF).Microbiol. Immunol.36: 773.
14.
GillitzerR., RitterU., SpandauU., GoebelerM., and BrockerE.B.. 1996. Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo.J. Invest. Dermatol.107: 778.
15.
MarokR., WinyardP.G., CoumbeA., KusM.L., GaffneyK., BladesS., MappP.I., MorrisC.J., BlakeD.R., KaltschmidtC., and BaeuerleP.A.. 1996. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue.Arthritis Rheum.39: 583.
16.
HanZ., ChangL., YamanishiY., KarinM., and FiresteinG.S.. 2002. Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis.Arthritis Rheum.46: 818.
17.
HanZ., BoyleD.L., ChangL., BennettB., KarinM., YangL., ManningA.M., and FiresteinG.S.. 2001. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.J. Clin. Invest.108: 73.
18.
KarinM., and DelhaseM.. 2000. The IB kinase (IKK) and NF-κB: key elements of proinflammatory signalling.Semin. Immunol.12:85.
19.
HanZ., BoyleD.L., ManningA.M., and FiresteinG.S.. 1998. AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis.Autoimmunity28: 197.
20.
TsaiC., DiazL.A.Jr., SingerN.G., LiL.L., KirschA.H., MitraR., NickoloffB.J., CroffordL.J., and FoxD.A.. 1996. Responsiveness of human Tlymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytes.Arthritis Rheum.39: 125.
21.
PierceJ.W., SchoenleberR., JesmokG., BestJ., MooreS.A., CollinsT., and GerritsenM.E.. 1997. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo.J. Biol. Chem.272: 21096.
22.
IsomakiP., and PunnonenJ.. 1997. Pro- and anti-inflammatory cytokines in rheumatoid arthritis.Ann. Med.29: 499.
23.
AlaaeddineN., Di BattistaJ.A., PelletierJ.P., KiansaK., CloutierJ.M., and Martel-PelletierJ.. 1999. Differential effects of IL-8, LIF (pro-inflammatory) and IL-11 (anti-inflammatory) on TNF-alpha-induced PGE(2)release and on signalling pathways in human OA synovial fibroblast.Cytokine11: 1020.
24.
SerhanC.N., and ChiangN.. 2002. Lipid-derived mediators in endogenous anti-inflammation and resolution: Lipoxins and aspirin-triggered 15-epi-Lipoxins.Scientific World Journal.2:169.
25.
SerhanC.N.. 2002. Lipoxins and aspirin triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution.Prostaglandins Other Lipid Medial.68: 433.
26.
TakanoT., FioreS., MaddoxJ.F., BradyH.R., PetasisN.A., and SerhanC.N.. 1997. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors.J. Exp. Med.185: 1693.
27.
ClishC.B., O'BrienJ.A., GronertK., StahlG.L., PetasisN.A., and SerhanC.N.. 1999. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo.Proc. Natl. Acad. Sci. U S A96: 8247.
28.
Sodin-SemrlS., TaddeoB., TsengD., VargaJ., and FioreS.. 2000. Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases.J. Immunol.164: 2660.
29.
FioreS., Sodin-SemrlS., KangY., and VargaJ.. 2000. Activation of LXA4R or serum amyloid A results in opposite regulation of NF-kB DNA binding in human synovial fibroblasts.Arthritis Rheum.43: S158.
30.
DevchandP.R., AritaM., HongS., BannenbergG., MousignacR.L., GronertK., and SerhanC.N.. 2003. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense.FASEB J.17: 652.
31.
GewirtzA.T., Collier-HyamsL.S., YoungA.N., KucharzikT., GuilfordW.J., ParkinsonJ.F., WilliamsI.R., NeishA.S., and MadaraJ.L.. 2002. Lipoxin A4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis.J. Immunol.168: 5260.
32.
FurlanetoC.J., and CampaA.. 2000. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil.Biochem. Biophys. Res. Commun.268: 405.
33.
HeR., SangH., and YeR.D.. 2003. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R.Blood101: 1572.
34.
PatelH., FellowesR., CoadeS., and WooP.. 1998. Human serum amyloid A has cytokine-like properties.Scand. J. Immunol.48: 410.
35.
CunnaneG., GrehanS., GeogheganS., McCormackC., ShieldsD., WhiteheadA.S., BresnihanB., and FitzgeraldO.. 2000. Serum amyloid A in the assessment of early inflammatory arthritis.J. Rheumatol.27: 58.
36.
UhlarC.M., and WhiteheadA.S.. 1999. Serum amyloid A, the major vertebrate acute-phase reactant.Eur. J. Biochem.265: 501.
37.
YapS.H., MoshageH.J., HazenbergB.P., RoelofsH.M., BijzetJ., LimburgP.C., AardenL.A., and van RijswijkM.H.. 1991. Tumor necrosis factor (TNF) inhibits interleukin (IL)-l and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes.Biochim. Biophys. Acta1091: 405.
38.
KalmovarinN., FriedrichsW.E., O'BrienH.V., LinehanL.A., BowmanB.H., and YangF.. 1991. Extrahepatic expression of plasma protein genes during inflammation.Inflamm.15: 369.
39.
SuS.B., GongW., GaoJ.L., ShenW., MurphyP.M., OppenheimJ.J., and WangJ.M.. 1999. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells.J. Exp. Med.189: 395.
40.
FioreS., and SerhanC.N.. 1995. Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD 11/18 expression by lipoxin A4-lipoxin A4 receptor interaction.Biochem.34: 16678.
41.
JungY.D., FanF., McConkeyD.J., JeanM.E., LiuW., ReinmuthN., StoeltzingO., AhmadS.A., ParikhA.A., MukaidaN., and EllisL.M.. 2002. Role of P38 MAPK, AP-1, and NF-kappaB in interleukin-1 beta-induced IL-8 expression in human vascular smooth muscle cells.Cytokine18: 206.
42.
FioreS., MaddoxJ.F., PerezH.D., and SerhanC.N.. 1994. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor.J. Exp. Med.180: 253.
43.
FioreS., RyeomS.W., WellerP.F., and SerhanC.N.. 1992. Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils.J. of Biol. Chem.267: 16168.
44.
FierroI.M., and SerhanC.N.. 2001. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins.Braz. J. of Med. and Biol. Res.34: 555.
45.
MitchellS., ThomasG., HarveyK., CottellD., Revillek., BerlasconiG., PetasisN.A., ErwigL., ReesA.J., SavillJ., BradyH.R., and GodsonC.. 2002. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo.J. Am. Soc. Nephrol.13:2497.
46.
FierroI.M., KutokJ.L., and SerhanC.N.. 2002. Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-Lipoxin A4 and Lipoxin A4.J. Pharmacol Exp. Therap.300: 385.
47.
McMahonB., MitchellD., ShattockR., MartinF., BradyH.R., and GodsonC.. 2002. Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation.FASEB J.16: 1817.
48.
SerhanC.N.. 1997. Lipoxins and novel aspirin-triggered 15 epi-lipoxins (ATL): jungle of cell-cell interactions or therapeutic opportunity?Prostaglandins53: 107.
49.
ChiangN., FierroI.M., GronertK., and SerhanC.N.. 2000. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation.J. Exp. Med.191: 1197.
50.
ResnatiM., PallaviciniI., WangJ.M., OppenheimJ., SerhanC.N., RomanoM., and BlasiF.. 2002. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LX A4R.Proc. Nat. Acad. Sci. of USA99: 1359.
51.
PerrettiM., ChiangN., LaM., FierroI.M., MarulloS., GettingS.J., SolitoE., and SerhanC.N.. 2002. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A(4) receptor.Nat. Med.8: 1296.
52.
MigitaK., KawabeY., TominagaM., OriguchiT., AoyagiT., and EguchiK.. 1998. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts.Lab. Invest.78: 535.
53.
MitchellT.I, JeffreyJ.J., PalmiterR.D., and BrinckerhoffC.E.. 1993. The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin.Biochim. Biophys. Acta1156: 245.
54.
RayA., and RayB.K.. 1999. Persistent expression of serum amyloid A during experimentally induced chronic inflammatory condition in rabbit involves differential activation of SAF, NF-kappa B, and C/EBP transcription factors.J. Immunol.163: 2143.
55.
LiX.X., and LiaoW.S.. 1991. Expression of rat serum amyloid Al gene involves both C/EBP-like and NF kappa B-like transcription factors.J. Biol. Chem.266: 15192.
56.
IguchiA., KitajimaI., YamakuchiM., UenoS., AikouT., KuboT., MatsushimaK., MukaidaN., and MaruyamaI.. 2000. PEA3 and AP-1 are required for constitutive IL-8 gene expression in hepatoma cells.Biochem. Biophys. Res. Commun.279: 166.
